There are over 100 preclinical studies on BPC-157 but zero completed Phase III human clinical trials
Login / Register Widget Access Your Research Portal Sign in or create your free account to unlock exclusive pricing, COAs, and bulk discounts
Round 1 : Host WRX Club Victoria Round 2 : Host AROCA Round 3 : Host MSCA Round 4 : Host FFCC Round 5
Experience luxury, results-driven skincare with advanced treatments designed to rejuvenate and refine your skin
Although research on intranasal administration of BPC-157 is extremely limited, broad studies on the potential benefits of intranasally administered peptide therapeutics suggest that this may be a beneficial RoA [11, 12]
It is not a treatment, cure or preventive therapy for any medical condition, including chronic fatigue syndrome, neurodegenerative disease, addiction, depression or metabolic disease, and it is not a way to reverse ageing